المؤلفون: Esteso Hontoria, Olga

مرشدي الرسالة: Guilarte Clavero, Mar, Cardona Dahl, Victòria, Selva O'Callaghan, Albert

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Anafilaxia, Ciències de la Salut

الوقت: 616.2

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/672518Test

المؤلفون: Abril Gil, Maria del Mar

المساهمون: University/Department: Universitat de Barcelona. Departament de Fisiologia (Farmàcia)

مرشدي الرسالة: Castell, Margarida, Franch i Masferrer, Àngels

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Al·lèrgia alimentària, Alergia a los alimentos, Food allergy, Cacau, Cacao, Cocoa, Flavonoides, Flavonoids, Anafilaxi, Anafilaxia, Anaphylaxis, Resposta immunitària, Respuesta inmune, Immune response, Ciències de la Salut

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/300892Test

المؤلفون: Vázquez Ortiz, Marta

المساهمون: University/Department: Universitat de Barcelona. Departament d'Obstetrícia i Ginecologia, Pediatria i Radiologia i Medicina Física

مرشدي الرسالة: Martín Mateos, M. A. (María Anunciación)

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Pediatria, Pediatría, Pediatrics, Immunoteràpia, Inmunoterapia, Immunotheraphy, Al·lèrgia alimentària, Alergia a los alimentos, Food allergy, Anafilaxi, Anafilaxia, Anaphylaxis, Ciències de la Salut

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/134696Test

المؤلفون: Sala Cunill, Anna

المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

مرشدي الرسالة: Cardona Dahl, Victòria, Bosch Gil, Josep Àngel

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Anafilaxia, Mastocit, Triptasa, Ciències de la Salut

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/107955Test

المؤلفون: Leidy Johana Alzate-Pérez, Natalia Aguirre Morales, Libia Susana Diez Zuluaga

المصدر: Revista Alergia México, Vol 71, Iss 1 (2024)

مصطلحات موضوعية: Hipersensibilidad a los Alimentos, Fabaceae, Anafilaxia, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://revistaalergia.mx/ojs/index.php/ram/article/view/1358Test; https://doaj.org/toc/0002-5151Test; https://doaj.org/toc/2448-9190Test

الوصول الحر: https://doaj.org/article/8f935e0f84244cce878649a7bc585de4Test

المؤلفون: Ivàn Tinoco Moran, Oscar Calderón Llosa, Margarita Olivares Gómez, Víctor Farinango Salazar, Iván Chérrez Ojeda

المصدر: Revista Alergia México, Vol 71, Iss 1 (2024)

مصطلحات موضوعية: Alergia ocular, Anafilaxia, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://revistaalergia.mx/ojs/index.php/ram/article/view/1324Test; https://doaj.org/toc/0002-5151Test; https://doaj.org/toc/2448-9190Test

الوصول الحر: https://doaj.org/article/1be5cd8dbb914e80a0721eaba8766169Test

المؤلفون: Jorge Herrera, Oswaldo Mauricio León Cabrera, Wilmer Stalin Sanango Reinoso, Soraya Puertas Azanza, Carmen Maricela Sevilla Rodríguez

المصدر: REV SEN, Vol 12, Iss 1 (2024)

مصطلحات موضوعية: Parada cardíaca, Anafilaxia, Etiología, Diálisis renal, Reporte de caso, Medicine (General), R5-920, Diseases of the genitourinary system. Urology, RC870-923, Internal medicine, RC31-1245

وصف الملف: electronic resource

العلاقة: http://rev-sen.ec/index.php/revista-nefrologia/article/view/73Test; https://doaj.org/toc/2953-6448Test

الوصول الحر: https://doaj.org/article/437467170e464990a2d2a2a5381d06faTest

المؤلفون: Sampaio Marques, Alberto, Gomes Chermont, Aurimery

المصدر: RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 No. 2 (2024): CLICK HERE TO ACCESS THE ARTICLES; e524798 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 Núm. 2 (2024): HAGA CLIC AQUÍ PARA ACCEDER A LOS ARTÍCULOS; e524798 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; v. 5 n. 2 (2024): CLIQUE AQUI PARA ACESSAR OS ARTIGOS; e524798 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 N.º 2 (2024): CLIQUE AQUI PARA ACESSAR OS ARTIGOS; e524798 ; 2675-6218

مصطلحات موضوعية: Anafilaxia. Reacción de hipersensibilidad. Alérgenos. Niños, Anaphylaxis. Hypersensitivity reaction. Allergens. Children, Anafilaxia, Reação de hipersensibilidade, Alérgenos, Crianças, Rejeição de hipersensibilidade

وصف الملف: application/pdf

العلاقة: https://recima21.com.br/index.php/recima21/article/view/4798/3370Test; https://recima21.com.br/index.php/recima21/article/view/4798Test

الإتاحة: https://doi.org/10.47820/recima21.v5i2.4798Test
https://recima21.com.br/index.php/recima21/article/view/4798Test

المؤلفون: Coelho, Cristina, Pereira, Liliana Patrícia, Santa, Cátia, Pedrosa, Cláudia

المصدر: NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL; Vol. 32 No. 4 (2023); 263-268 ; NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL; Vol. 32 N.º 4 (2023); 263-268 ; 2183-9417

مصطلحات موضوعية: epinephrine, allergy, anaphylaxis, children, Pediatrics, alergia, anafilaxia, criança, epinefrina, Pediatria

وصف الملف: application/pdf

العلاقة: https://revistas.rcaap.pt/nascercrescer/article/view/29358/24067Test; https://revistas.rcaap.pt/nascercrescer/article/view/29358Test

الإتاحة: https://revistas.rcaap.pt/nascercrescer/article/view/29358Test

المؤلفون: Franco Lacato, Alex Omar, Samper, Dayanis Moreno, Chaparro Mérida, Nataniel Aldo

المساهمون: Ningún organismo

المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 43 (2024): Publicación continua ; 1561-3011 ; 0864-0300

مصطلحات موضوعية: vaccine, SARS-CoV-2, COVID-19, hypersensitivity, anaphylaxis, vacuna, hipersensibilidad, anafilaxia

وصف الملف: application/pdf

العلاقة: https://revibiomedica.sld.cu/index.php/ibi/article/view/2004/1554Test; Araf Y, Faruqui NA, Anwar S, Hosen MJ. SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol. 2021;24(1):19-24. DOI: https://doi.org/10.1007%2Fs10123-020-00152-yTest 2. V'Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155-70. DOI: https://doi.org/10.1038%2Fs41579-020-00468-6Test 3. Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J. Vaccines and drug therapeutics to lock down novel coronavirus disease 2019 (COVID-19): a systematic review of clinical trials. Cureus. 2020;12(5):e8342. DOI: https://doi.org/10.7759%2Fcureus.8342Test 4. Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384(23):2202-11. DOI: https://doi.org/10.1056/NEJMoa2105385Test 5. Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infect Genet Evol. 2020;83:104327. DOI: https://doi.org/10.1016%2Fj.meegid.2020.104327Test 6. Petersen E, Lucey D, Blumberg L, Kramer LD, Al-Abri S, Lee SS, et al. COVID-19 vaccines under the International Health Regulations–We must use the WHO International Certificate of Vaccination or Prophylaxis. Int J Infect Dis. 2021;104:175-7. DOI: https://doi.org/10.1016/j.ijid.2021.01.039Test 7. Fritsche PJ, Helbling A, Ballmer-Weber BK. Vaccine hypersensitivity--update and overview. Swiss Med Wkly. 2010;140(17-18):238-46. DOI: http://dx.doi.org/10.5167/uzh-41741Test 8. McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141(2):463-72. DOI: https://doi.org/10.1016%2Fj.jaci.2017.12.971Test 9. Caubet JC, Ponvert C. Vaccine allergy. Immunol Allergy Clin North Am. 2014;34(3):597-613. DOI: https://doi.org/10.1016/j.iac.2014.04.004Test 10. Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016;9(1):32. DOI: https://doi.org/10.1186%2Fs40413-016-0120-5Test 11. Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Vaccine. 2015;33(13):1602-7. DOI: https://doi.org/10.1016/j.vaccine.2015.02.008Test 12. Chung EH. Vaccine allergies. Clin Exp Vaccine Res. 2014;3(1):50-7. DOI: https://doi.org/10.7774%2Fcevr.2014.3.1.50Test 13. Kim HS, Engel S, Neveu D, Thollot Y, Oster P, Yang K. Post-marketing surveillance observational study of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-DT, MCV4/Menactra((R))) in the Republic of Korea, 2014-2019. Infect Dis Ther. 2021;10(1):399-409. DOI: https://doi.org/10.1007%2Fs40121-020-00393-4Test 14. Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):237. DOI: https://doi.org/10.1038/s41392-020-00352-yTest 15. Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E, et al. Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol. 2017;28(7):628-40. DOI: https://doi.org/10.1111/pai.12762Test 16. Kounis NG, Koniari I, de Gregorio C, Velissaris D, Petalas K, Brinia A, et al. Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines (Basel). 2021;9(3):221. DOI: https://doi.org/10.3390%2Fvaccines9030221Test 17. Caballero ML, Quirce S. Delayed hypersensitivity reactions caused by drug excipients: a literature review. J Investig Allergol Clin Immunol. 2020;30(6):400-8. DOI: https://doi.org/10.18176/jiaci.0562Test 18. Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134(6):1318-28.e7. DOI: https://doi.org/10.1016%2Fj.jaci.2014.08.018Test 19. Wylon K, Dolle S, Worm M. Polyethylene glycol as a cause of anaphylaxis. Allergy Asthma Clin Immunol. 2016;12:67. DOI: https://doi.org/10.1186/s13223-016-0172-7Test 20. Stone CA, Jr., Liu Y, Relling MV, Krantz MS, Pratt AL, Abreo A, et al. Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized. J Allergy Clin Immunol Pract. 2019;7(5):1533-40.e8. DOI: https://doi.org/10.1016%2Fj.jaip.2018.12.003Test 21. Garvey LH, Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth. 2021;126(3):e106-8. DOI: https://doi.org/10.1016%2Fj.bja.2020.12.020Test 22. Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol? Allergy. 2021;76(6):1617-8. DOI: https://doi.org/10.1111/all.14711Test 23. Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. AAPS PharmSciTech. 2020;21(6):225. DOI: https://doi.org/10.1208%2Fs12249-020-01744-7Test 24. Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023-34. DOI: https://doi.org/10.1016%2FS0140-6736Test(21)00306-8 25. Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Ebisawa M, El-Gamal Y, et al. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organ J. 2021;14(2):100517. DOI: https://doi.org/10.1016%2Fj.waojou.2021.100517Test 26. Tumban E. Lead SARS-CoV-2 Candidate vaccines: expectations from phase III trials and recommendations post-vaccine approval. Viruses. 2020;13(1):54. DOI: https://doi.org/10.3390%2Fv13010054Test 27. Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med. 2021;384(7):643-9. DOI: https://doi.org/10.1056/NEJMra203534Test 28. Anesi J. The advisory Committee on Immunization practices' updated interim recommendation for allocation of COVID-19 vaccine-United states, December 2020. Am J Transplant. 2021;21(2):897. DOI: https://doi.org/10.1111%2Fajt.16480Test 29. Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101-2. DOI: https://doi.org/10.1001/jama.2021.1967Test 30. Pardi N, Hogan MJ, Weissman D. Recent advances in mRNA vaccine technology. Curr Opin Immunol. 2020;65:14-20. DOI: https://doi.org/10.1016/j.coi.2020.01.008Test 31.Oliver SE, Gargano JW, Scobie H, Wallace M, Hadler SC, Leung J, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021;70(9):329-32. DOI: https://doi.org/10.15585%2Fmmwr.mm7009e4Test 32. Taneja V. Sex hormones determine immune response. Front Immunol. 2018;9(1931). DOI: https://doi.org/10.3389%2Ffimmu.2018.01931Test 33. Administration CC-RTaFaD. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46-51. DOI: http://dx.doi.org/10.15585/mmwr.mm7002e1Test 34. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-123. DOI: https://doi.org/10.1016/j.jaci.2020.01.017Test 35. Williams KW, Sharma HP. Anaphylaxis and urticaria. Immunol Allergy Clin North Am. 2015;35(1):199-219. DOI: https://doi.org/10.1016/j.iac.2014.09.010Test 36. Peavy RD, Metcalfe DD. Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8(4):310-5. DOI: https://doi.org/10.1097%2FACI.0b013e3283036a90Test 37. Ben-Shoshan M, Clarke AE. Anaphylaxis: past, present and future. Allergy. 2011;66(1):1-14. DOI: https://doi.org/10.1111/j.1398-9995.2010.02422.xTest 38. Finkelman FD, Khodoun MV, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 2016;137(6):1674-80. DOI: https://doi.org/10.1016%2Fj.jaci.2016.02.015Test 39. Mohamed M, Abu Lila AS, Shimizu T, Alaaeldin E, Hussein A, Sarhan HA, et al. PEGylated liposomes: immunological responses. Sci Technol Adv Mater. 2019;20(1):710-24. DOI: https://doi.org/10.1080%2F14686996.2019.1627174Test 40. Dézsi L, Mészáros T, Őrfi E, Fülöp TG, Hennies M, Rosivall L, et al. Complement activation-related pathophysiological changes in anesthetized rats: activator-dependent variations of symptoms and mediators of pseudoallergy. Molecules. 2019;24(18):3283. DOI: https://doi.org/10.3390%2Fmolecules24183283Test 41.Szebeni J. Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement? Drug Discov Today. 2018;23(3):487-92. DOI: https://doi.org/10.1016/j.drudis.2018.01.025Test 42. Bedőcs P, Szebeni J. The critical choice of animal models in nanomedicine safety assessment: a lesson learned from hemoglobin-based oxygen carriers. Front Immunol. 2020;11:584966. DOI: https://doi.org/10.3389/fimmu.2020.584966Test 43. Otte A, Soh BK, Yoon G, Park K. Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs. Int J Pharm. 2018;539(1-2):175-83. DOI: https://doi.org/10.1016/j.ijpharm.2018.01.037Test 44. Guilarte M, Sala-Cunill A, Luengo O, Labrador-Horrillo M, Cardona V. The mast cell, contact, and coagulation system connection in anaphylaxis. Front Immunol. 2017;8:846. DOI: https://doi.org/10.3389%2Ffimmu.2017.00846Test 45. Gao Y, Han Y, Zhang X, Fei Q, Qi R, Hou R, et al. Penicillin causes non-allergic anaphylaxis by activating the contact system. Sci Rep. 2020;10(1):14160. DOI: https://doi.org/10.1038%2Fs41598-020-71083-xTest 46. Bender L, Weidmann H, Rose-John S, Renné T, Long AT. Factor XII-driven inflammatory reactions with implications for anaphylaxis. Front Immunol. 2017;8:1115. DOI: https://doi.org/10.3389%2Ffimmu.2017.01115Test 47. Navines A, Serrano E, Lafuente A, Munoz R, Martin M, Gastaminza G. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep. 2018;8(1):11628. DOI: https://doi.org/10.1038%2Fs41598-018-29965-8Test 48. Porebski G, Kwiecien K, Pawica M, Kwitniewski M. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol. 2018;9:3027. DOI: https://doi.org/10.3389%2Ffimmu.2018.03027Test 49. von Hundelshausen P, Lorenz R, Siess W, Weber C. Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thromb Haemost. 2021;121(11):1395-99. DOI: https://doi.org/10.1055/a-1481-3039Test 50. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092-101. DOI: https://doi.org/10.1056/NEJMoa2104840Test 51. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. 2021;217(4). DOI: https://doi.org/10.2214/AJR.21.25604Test 52. Fernandez M, Rivero I, Calvache A, Martinon F. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Euro Surveill. 2021;26(10):2100193. DOI: https://doi.org/10.2807%2F1560-7917.ES.2021.26.10.2100193Test; https://revibiomedica.sld.cu/index.php/ibi/article/view/2004Test

الإتاحة: https://doi.org/10.1056/NEJMoa2105385Test
https://revibiomedica.sld.cu/index.php/ibi/article/view/2004Test